 |
 |
 |
||
|
||||
 |
|
| Updated Sep. 1, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
| |
|
Vandetanib Active Against Metastatic Thyroid Cancer
ISSUE: SEPTEMBER, 2010 The first Phase III trial with a tyrosine kinase inhibitor in advanced or metastatic medullary thyroid cancer has revealed that vandetanib (Zactima, AstraZeneca) can significantly improve progression-free survival. read more | |
|
Experts Debate Use of Maintenance Therapy for NSCLC
ISSUE: SEPTEMBER, 2010 Should maintenance therapy become the standard of care for advanced non-small cell lung cancer? This question was the topic of a lively debate at the annual meeting of the American Society of Clinical Oncology. Although some believe maintenance therapy is a must, others say it only is valuable in certain patients and may be cost-prohibitive. read more | |
|
Oncoplasty Interest Grows as Breast Cancer Option
ISSUE: SEPTEMBER, 2010 In recent years, interest in oncoplasty—some combination of oncologic and cosmetic techniques by surgeons for their breast cancer patients—has surged. read more | |
|
Study Finds 25% Rate of Colorectal Neoplasia in Hispanics
ISSUE: SEPTEMBER, 2010 A retrospective analysis of colonoscopic data from 745 asymptomatic Puerto Ricans has revealed a colorectal neoplasia prevalence of 25%. Men and older individuals were more likely to develop neoplasia, according to the study presented at the 2010 Digestive Diseases Week. The study fills an important knowledge gap regarding colorectal cancer prevalence among Hispanic Americans, and will help clinicians identify those at highest risk. read more | |
|
Drug Combination Improves Survival in Pancreatic Cancer
ISSUE: AUGUST, 2010 Clinicians have a new regimen to consider for the first-line treatment of certain patients with metastatic pancreatic cancer. First-line therapy with FOLFIRINOX, a combination of older chemotherapeutic drugs, improved median overall survival (OS) of certain patients with pancreatic cancer by four months (11.1 vs. 6.8 months) compared with gemcitabine (Gemzar, Eli Lilly). read more | |
|
Studies Challenge Value of Breast Cancer Procedures
ISSUE: AUGUST, 2010 The indications for immunohistochemistry and axillary lymph node dissections in clinically node-negative breast cancer have been narrowed considerably by a series of large studies presented consecutively at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO). These procedures do not appear to be helpful in several populations, if judged by the criterion that interventions are appropriate only if they change outcomes. read more | |
|
Experts Highlight ‘Need-to-Know’ ASCO Meeting News
ISSUE: AUGUST, 2010 What information do community oncologists need to incorporate into their practice from the recent annual meeting of the American Society of Clinical Oncology (ASCO)? In this column, several Clinical Oncology News advisory board members offer their picks on practice-changing and crucial news regarding breast, colon, prostate, kidney and ovarian cancers. read more | |
|
Ipilimumab Improves Survival In Advanced Melanoma
ISSUE: JULY, 2010 A monoclonal antibody with a unique mechanism of action has become the first drug ever to demonstrate a survival benefit in previously treated advanced melanoma. The benefit of ipilimumab (Bristol-Myers Squibb), achieved with relatively modest toxicity, was demonstrated in a multinational Phase III study presented at the annual meeting of the American Society of Clinical Oncology. read more (2 comments) |
2 | |
| MORESOLID TUMORS | |
| |
|
• |
Eribulin Improves Survival in Metastatic Breast Ca... [7/2010] |
|
• |
Bevacizumab: Ready for Prime Time in Ovarian Cance... [7/2010] |
|
• |
Targeted Agent Shows Impressive Activity in NSCLC ... [7/2010] |
|
• |
Hormone Therapy and Radiation Is New Standard... [7/2010] |
|
• |
Paradigm Change Suggested for Ovarian Cancer ... [6/2010] |
|
• |
BATTLE May Redefine Treatment Approach to Lung Ca ... [6/2010] |
|
• |
Breast Cancer Guidelines Released... [6/2010] |
|
• |
Alarming Pattern Identified for Bone Metastases... [6/2010] |
|
• |
Prostate Cancer Drug Promising for Unmet Need ... [4/2010] |
|
• |
Large Trial Correlates Anal Cancer TN Staging With... [4/2010] |
|
• |
Genetic Markers Identified for Poor Outcome in Gas... [4/2010] |
|
• |
Hurdling the Challenges of Anti-angiogenic Therapy... [4/2010] |
|
• |
In Patients With CRC … BRAF Mutations Solidified a... [3/2010] |
|
• |
Radioactive Seed Localization: A New Gold Standard... [3/2010] |
|
• |
Modified DCF Regimen Reduces Toxicity in Gastric C... [3/2010] |
 Solid Tumors Archives | |
| home | about us | advertise | contact | publications |